Clinical Trials in Shanxi, China
6 recruiting
Showing 1–12 of 12 trials
Recruiting
Phase 3
A Long-term Extension Study of PCI-32765 (Ibrutinib)
Diffuse Large B Cell LymphomaChronic Lymphocytic LeukemiaMantle Cell Lymphoma+4 more
Janssen Research & Development, LLC700 enrolled174 locationsNCT01804686
Recruiting
Phase 1Phase 2
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Triple-Negative Breast CancerEndometrial CancerPrimary Peritoneal Carcinoma+12 more
Genmab764 enrolled67 locationsNCT05579366
Recruiting
Phase 3
Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer
Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Gilead Sciences695 enrolled204 locationsNCT06801834
Recruiting
Phase 3
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Atrial Fibrillation (AF)
Anthos Therapeutics, Inc.1,900 enrolled721 locationsNCT05712200
Recruiting
Phase 3
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Metastatic Breast Cancer
Sermonix Pharmaceuticals Inc.500 enrolled222 locationsNCT05696626
Recruiting
Phase 2
Neoadjuvant Chemotherapy Combined With Toripalimab for TNBC (NEOTORCH-BREAST02)
First Affiliated Hospital of Zhejiang University35 enrolled13 locationsNCT06682195
Recruiting
Phase 2
Nimotuzumab Combined With Toripalimab and Chemotherapy for Locally Advanced Tonsillar Cancer
Head & Neck Cancer
Tang-Du Hospital10 enrolled1 locationNCT07353723
Recruiting
This is a Non-interventional, Study to Assess Demographic Characteristics and Patient Reported Outcomes in China Patients With SEA Treated With Benralizumab
Chronic Obstructive Pulmonary Disease
AstraZeneca1,000 enrolled16 locationsNCT06862206
Recruiting
Phase 4
A Retrospective and Prospective Real-world Study of Molecular Typing in the Treatment of Advanced Thyroid Cancer
Advanced Thyroid Cancer Patients Who Received Target Therapy
Fudan University800 enrolled8 locationsNCT06195228
Recruiting
Selection and Efficacy-Influencing Factors of First-Line Biologic Agents in Moderate-to-Severe Ulcerative Colitis
Ulcerative Colitis (UC)
Xijing Hospital of Digestive Diseases400 enrolled1 locationNCT06962020
Recruiting
Phase 3
A Phase III Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension in China
Open Angle GlaucomaOcular Hypertension
Santen Pharmaceutical Co., Ltd.338 enrolled25 locationsNCT06666855
Recruiting
Registry of Multicenter Brain-Heart Comorbidity in China
Heart FailureAtrial FibrillationCardiac Arrest+10 more
Beijing Tiantan Hospital100,000 enrolled14 locationsNCT05961748